financetom
MD
financetom
/
Healthcare
/
MD
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Pediatrix Medical Group, Inc.MD
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States.

It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors.

In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients.

Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments.

The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022.

Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Latest News >
Research Alert: CFRA Keeps Hold Opinion On Shares Of Quanta Services, Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Quanta Services, Inc.
May 2, 2024
02:25 PM EDT, 05/02/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our target to $265 from $235, valuing shares at 27.6x our 2025 EPS estimate, a premium to PWR's three-year average of 23.8x. We believe the premium is warranted...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Sabre Corporation
Research Alert: CFRA Maintains Buy Opinion On Shares Of Sabre Corporation
May 2, 2024
02:15 PM EDT, 05/02/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our target by $0.30 to $3.50, using an EV/sales ratio of 1.9x our 2024 sales view, below peers and SABR's three-year average (~2.4x) on its high debt load...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Ventas, Inc.
Research Alert: CFRA Maintains Buy Opinion On Shares Of Ventas, Inc.
May 2, 2024
02:05 PM EDT, 05/02/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our target by $2 to $52 on a forward P/FFO of 16.5x our 2024 FFO estimate, a premium to VTR's 15.5x 10-year average due to favorable demographic tailwinds...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Advanced Energy Industries, Inc.
Research Alert: CFRA Maintains Hold Opinion On Shares Of Advanced Energy Industries, Inc.
May 2, 2024
02:25 PM EDT, 05/02/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We cut our 12-month target by $8 to $100 on a P/E of 18x our 2025 EPS view, in line with EMS peers. We cut our 2024 EPS view to...
Copyright 2023-2025 - www.financetom.com All Rights Reserved